相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Doxorubicin pathways: pharmacodynamics and adverse effects
Caroline F. Thorn et al.
PHARMACOGENETICS AND GENOMICS (2011)
Kinetic studies of AKR1B10, human aldose reductase-like protein: Endogenous substrates and inhibition by steroids
Satoshi Endo et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)
Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes
Hans-Joerg Martin et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
Stephen A. Bustin et al.
CLINICAL CHEMISTRY (2009)
Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance
Zachary W. Veitch et al.
PHARMACOGENETICS AND GENOMICS (2009)
Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance
Stacey L. Hembruff et al.
BMC CANCER (2008)
Reduction of doxorubicin and oracin and induction of carbonyl reductase in human breast carcinoma MCF-7 cells
Martina Gavelova et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2008)
Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver
Nina Kassner et al.
DRUG METABOLISM AND DISPOSITION (2008)
Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C3
Romana Novotna et al.
TOXICOLOGY LETTERS (2008)
Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms
Trevor M. Penning et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Tibolone metabolism in human liver is catalyzed by 3α/3β-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR)1C subfamily
S Steckelbroeck et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The optimization of quantitative reverse transcription PCR for verification of cDNA microarray data
SL Hembruff et al.
ANALYTICAL BIOCHEMISTRY (2005)
Characterization of the organic cation transporter SLC22A16: A doxorubicin importer
M Okabe et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Extension of murine life span by overexpression of catalase targeted to mitochondria
SE Schriner et al.
SCIENCE (2005)
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma
NY Frank et al.
CANCER RESEARCH (2005)
Cyclosporin A is a broad-spectrum multidrug. resistance modulator
M Qadir et al.
CLINICAL CANCER RESEARCH (2005)
Efflux transporters and their clinical relevance
V Fischer et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
Reactome: a knowledgebase of biological pathways
G Joshi-Tope et al.
NUCLEIC ACIDS RESEARCH (2005)
Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3α-hydroxysteroid dehydrogenase/type 5 17β-hydroxysteroid dehydrogenase);: immunohistochemical detection in breast and prostate
HK Lin et al.
STEROIDS (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
LA Doyle et al.
ONCOGENE (2003)
Anthracycline secondary alcohol metabolite formation in human or rabbit heart: biochemical aspects and pharmacologic implications
A Mordente et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Subcellular localization and activity of multidrug resistance proteins
A Rajagopal et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Pathway studio - the analysis and navigation of molecular networks
A Nikitin et al.
BIOINFORMATICS (2003)
The role of ABC transporters in clinical practice
GD Leonard et al.
ONCOLOGIST (2003)
GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways
KD Dahlquist et al.
NATURE GENETICS (2002)
A simple, high-resolution method for establishing DNA binding affinity and sequence selectivity
DL Boger et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Transcription, genomes, function
RJ Cho et al.
TRENDS IN GENETICS (2000)
A family of drug transporters: The multidrug resistance-associated proteins
P Borst et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells
A Chadderton et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
分享论文
